title: Therapeutic actions of L-deprenyl in dogs: a model of human brain aging.
authors.affiliation: Deprenyl Animal Health, Inc., Overland Park, Kansas 66210, USA.
authors.forename: W W
authors.initials: WW
authors.lastname: Ruehl
authors.forename: J
authors.initials: J
authors.lastname: Neilson
authors.forename: B
authors.initials: B
authors.lastname: Hart
authors.forename: E
authors.initials: E
authors.lastname: Head
authors.forename: D S
authors.initials: DS
authors.lastname: Bruyette
authors.forename: B J
authors.initials: BJ
authors.lastname: Cummings
mesh_terms: D000375:Aging / Q000502:physiology*; D000818:Animals; D001921:Brain / Q000187:drug effects / Q000254:growth & development / Q000473:pathology; D003072:Cognition Disorders / Q000209:etiology / Q000517:prevention & control; D003704:Dementia / Q000517:prevention & control*; D004285:Dogs; D006801:Humans; D008954:Models, Biological; D008995:Monoamine Oxidase / Q000378:metabolism; D008996:Monoamine Oxidase Inhibitors / Q000627:therapeutic use*; D012642:Selegiline / Q000627:therapeutic use*
chemical_list: D008996:Monoamine Oxidase Inhibitors; D012642:Selegiline; D008995:Monoamine Oxidase